First-in-Human trial begins for potential cancer drug
NCT ID NCT07046559
Summary
This is a very early study to check if a new drug called LY4066708 is safe for people and to see how the body handles it. It will involve about 104 healthy volunteers who will receive the drug and be monitored for up to 24 weeks. The main goals are to identify any side effects and measure how much of the drug gets into the blood and brain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit
RECRUITINGHolbeck, Leeds, LS11 9EH, United Kingdom
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.